Peritoneal carcinomatosis (PC) of colorectal cancer (CRC) origin is associated with poor outcome. This systematic review evaluates the available evidence about adjuvant (hyperthermic) intraperitoneal chemotherapy ((H)IPEC) to prevent the development of PC. A systematic search of literature was conducted in August 2013 in PubMed, Embase, and the Cochrane database for studies on (H)IPEC to prevent PC in patients who underwent curative surgery for primary CRC. Seven comparative studies and five cohort studies were selected. Treatment schedules varied between repeated fluoropyrimidine-based IPEC administration in the ambulatory setting to intra-operative (H)IPEC procedures using mitomycin-C or oxaliplatin. The reported rates of major complicati...
BACKGROUND: Cytoreductive surgery and intraperitoneal chemotherapy has improved prognosis in patien...
SummaryIntroductionCompared with intravenous chemotherapy, cytoreductive surgery (CRS) and hyperther...
International audienceBackground:Peritoneal carcinomatosis in colorectal cancer is an advanced stage...
Peritoneal carcinomatosis (PC) of colorectal cancer (CRC) origin is associated with poor outcome. Th...
Background: The peritoneum is the second most common site of recurrence in colorectal cancer. Early ...
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
OBJECTIVE: To review the literature with regard to the incidence and prognostic significance of peri...
Approximately 5% of colorectal cancer (CRC) patients will develop peritoneal carcinomatosis (PC) in ...
Background Cytoreductive surgery (CRS) and intraperitoneal chemotherapy (IPC) treatment of colorecta...
Peritoneal carcinomatosis (PC) from gastric cancer is a condition with a very bleak prognosis. Most ...
Background: Today, we do not have a universally accepted evidence on how to treat peritoneal carcino...
Background: The objective of the present meta-analysis was to analyze the survival outcomes of patie...
Background Nearly a quarter of patients with locally advanced (T4 stage) or perforated colon cancer ...
Up to 25% of patients with metastatic colorectal cancer (CRC) present with peritoneal carcinomatosis...
BACKGROUND: Cytoreductive surgery and intraperitoneal chemotherapy has improved prognosis in patien...
SummaryIntroductionCompared with intravenous chemotherapy, cytoreductive surgery (CRS) and hyperther...
International audienceBackground:Peritoneal carcinomatosis in colorectal cancer is an advanced stage...
Peritoneal carcinomatosis (PC) of colorectal cancer (CRC) origin is associated with poor outcome. Th...
Background: The peritoneum is the second most common site of recurrence in colorectal cancer. Early ...
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
OBJECTIVE: To review the literature with regard to the incidence and prognostic significance of peri...
Approximately 5% of colorectal cancer (CRC) patients will develop peritoneal carcinomatosis (PC) in ...
Background Cytoreductive surgery (CRS) and intraperitoneal chemotherapy (IPC) treatment of colorecta...
Peritoneal carcinomatosis (PC) from gastric cancer is a condition with a very bleak prognosis. Most ...
Background: Today, we do not have a universally accepted evidence on how to treat peritoneal carcino...
Background: The objective of the present meta-analysis was to analyze the survival outcomes of patie...
Background Nearly a quarter of patients with locally advanced (T4 stage) or perforated colon cancer ...
Up to 25% of patients with metastatic colorectal cancer (CRC) present with peritoneal carcinomatosis...
BACKGROUND: Cytoreductive surgery and intraperitoneal chemotherapy has improved prognosis in patien...
SummaryIntroductionCompared with intravenous chemotherapy, cytoreductive surgery (CRS) and hyperther...
International audienceBackground:Peritoneal carcinomatosis in colorectal cancer is an advanced stage...